The Role of Negative-Pressure Wound Therapy in Patients with Fracture-Related Infection: A Systematic Review and

Susan Haidari1, Frank F A IJpma2, Willem-Jan Metsemakers3

  • 1Department of Trauma Surgery, University Medical Center Utrecht, Utrecht, Netherlands.

Abstract

Insights

Negative-pressure wound therapy (NPWT) is used for fracture-related infections (FRI), but evidence on its impact on infection recurrence is limited. This review suggests NPWT may be safe short-term but not definitive treatment for FRI.

Area of Science:

  • Orthopedic Surgery
  • Trauma Management
  • Wound Care

Background:

  • Fracture-related infection (FRI) is a serious complication in orthopedic trauma surgery.
  • Negative-pressure wound therapy (NPWT) is commonly used for wound management, including in FRI cases.
  • The efficacy of NPWT in managing FRI, particularly regarding infection recurrence, remains debated.

Purpose of the Study:

  • To qualitatively assess the existing literature on the role of NPWT in the management of FRI.
  • To evaluate the impact of NPWT on infection recurrence in patients with FRI.

Main Methods:

  • A systematic literature search was conducted across PubMed, Embase, and Web of Science.
  • Studies focusing on infection recurrence in FRI managed with NPWT were included.
  • Quality assessment utilized PRISMA guidelines and the Newcastle-Ottawa Scale.

Main Results:

  • Eight studies were included, with infection recurrence rates varying from 2.8% to 34.9%.
  • Wound healing times ranged from two to seven weeks across six studies.
  • Microbial swabs during NPWT showed new pathogens in one study (23%), but not in three others.

Conclusions:

  • Current literature lacks uniform data, necessitating cautious interpretation of findings on NPWT for FRI.
  • There is insufficient scientific evidence to support NPWT as a definitive treatment for FRI.
  • Early soft tissue coverage (e.g., flaps) is recommended, with NPWT potentially serving as safe temporary coverage for a few days.